Protocol approach 1: immune rebalancing (thymosin alpha-1 plus KPV) Goal: Restore regulatory immune function while reducing inflammatory signaling Components: Thymosin alpha-1: 1.6 mg subcutaneously twice per week (promotes Treg expansion, modulates dendritic cells) KPV: 200-500 mcg daily, orally or subcutaneously (inhibits NF-kB, reduces TNF-alpha and IL-6) Rationale: Thymosin alpha-1 works at the cellular level to rebuild the regulatory arm of the immune system, while KPV addresses the inflammatory signaling that drives acute symptoms
If your primary goal is more significant weight loss or you have established cardiovascular disease, Wegovy is typically the stronger option
Monitoring Blood glucose levels A1C testing Weight changes Symptoms of pancreatitis or thyroid issues Who This Medication Is For Semaglutide is prescribed for: Adults with type 2 diabetes needing improved blood sugar control Adults with type 2 diabetes and established cardiovascular disease Adults with obesity or overweight with related health conditions (depending on formulation approval) It is intended for chronic management under medical supervision
Similarly, GLP-1 drugs started out as treatments for diabetes before being used for weight loss, and they are now moving into new territory
GLP-1 agonists showed a higher reduction of HbA1c compared to placebo when including only obese patients, MD -0.60, 95% CI , -1.06--0.13
